American Society for Radiation Oncology (ASTRO) shared a post on X about a paper by Rachel Glicksman et al. published in the International Journal of Radiation Oncology, Biology, Physics:
“Radiotherapy or chemotherapy for stage 2A/B seminoma? Large institutional data suggests excellent cancer outcomes with both.
Read Rachel Glicksman, Rob Hamilton, Philippe Bedard, Radiation Medicine Program et al.’s work in the Red Journal.”
Authors: Rachel Glicksman, Di Maria Jiang, Philippe Bedard, Padraig Warde, Peter Chung et al.
More posts featuring ASTRO.